Distinguished in Hemolysis

Dr. Caterina P. Minniti

Pediatric Hematology Oncology
111 Michigan Ave Nw, 
Washington, DC 
Distinguished in Hemolysis
111 Michigan Ave Nw, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Caterina Minniti is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Minniti is rated as a Distinguished provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Her clinical research consists of co-authoring 97 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Hemolysis.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in DC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

111 Michigan Ave Nw, Washington, DC 20010

Additional Areas of Focus

Dr. Minniti has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
Enrollment Status: Completed
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2
An Open-Label, Expanded Access Protocol for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
An Open-Label, Expanded Access Protocol for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
Enrollment Status: No_longer_available
Publish Date: July 18, 2023
Intervention Type: Drug
View 2 Less Clinical Trials

96 Total Publications

Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.
Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies.
Journal: Blood reviews
Published: December 28, 2024
Similar Doctors
Elite in Hemolysis
Dr. Gregory J. Kato
Pediatric Hematology Oncology
Elite in Hemolysis
Dr. Gregory J. Kato
Pediatric Hematology Oncology
10 Center Dr, Building 10crc, Rm 5-5140, 
Bethesda, MD 
 (7.1 miles away)
301-451-8497
Languages Spoken:
English
See accepted insurances

Gregory Kato is a Pediatric Hematologist Oncology provider in Bethesda, Maryland. Dr. Kato is rated as an Elite provider by MediFind in the treatment of Hemolysis. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Experienced in Hemolysis
Dr. Courtney D. Fitzhugh
Pediatric Hematology Oncology
Experienced in Hemolysis
Dr. Courtney D. Fitzhugh
Pediatric Hematology Oncology
600 N Wolfe St, Cmsc-800, 
Baltimore, MD 
 (34.2 miles away)
410-644-5055
Languages Spoken:
English

Courtney Fitzhugh is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Fitzhugh is rated as a Distinguished provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Experienced in Hemolysis
Dr. Robert Nickel
Pediatric Hematology Oncology
Experienced in Hemolysis
Dr. Robert Nickel
Pediatric Hematology Oncology

Children's Hospital

111 Michigan Ave Nw, 
Washington, DC 
 (0.1 miles away)
202-476-5000
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Robert Nickel is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Nickel has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Hemolysis. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Minniti's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile